Full-Time

Director – Clinical Operations

Confirmed live in the last 24 hours

Kymera Therapeutics

Kymera Therapeutics

201-500 employees

Develops small molecule protein degraders for diseases

Biotechnology

Senior

Belmont, MA, USA

Required Skills
Communications
Requirements
  • BA/BS preferably in a health-related field; preferred MA/MS degree with major in biological, life science, nursing or related field
  • 10 + years of experience in clinical operations management within the pharmaceutical or biotechnology industry
  • Prior experience building and leading a team is a plus
  • Expertise in global regulatory and compliance requirements for clinical research, including but not limited to, US CRF, EU CTD and ICH GCP
  • Ability to manage multiple competing priorities and adapt to changes
  • Strong communication, interpersonal, and problem-solving skills
  • Must be comfortable working in a fast-paced environment
Responsibilities
  • Lead and oversee the strategic planning, implementation and execution of clinical trials across a key immunology program
  • Develop and manage comprehensive program project plans, including study protocols, clinical trial budgets, timelines, enrollment and risk mitigation strategies
  • Collaborate cross-functionally with internal teams to ensure alignment on clinical trial objectives and milestones
  • Provide operational expertise and strategic input into the development of Clinical Development Plans (CDP)
  • Serve as the point of contact for CROs and vendors, overseeing their performance and ensuring adherence to contractual agreements, timelines and quality standards
  • Ensure compliance with regulatory requirements, ICH-GCP requirements, and company SOPs throughout all stages of clinical trial conduct
  • Oversee the collection, analysis and interpretation of clinical trial data
  • Contribute to the preparation and review of clinical study documents
  • In collaboration with the Head of Clinical Operations, hire, train and develop the Clinical Operations team

Kymera Therapeutics is at the forefront of utilizing its proprietary Pegasus platform to develop small molecule protein degraders, targeting specific disease-causing proteins in critical areas like immunology-inflammation and oncology. This offers a dynamic workplace with a focus on cutting-edge technology and treatments that could drastically improve patient outcomes in significant disease domains. The company's commitment to advancing medical science and its technical proficiency provides a stimulating environment for professionals passionate about making a tangible impact on healthcare.

Company Stage

IPO

Total Funding

$879M

Headquarters

Watertown, Massachusetts

Founded

2016

Growth & Insights
Headcount

6 month growth

0%

1 year growth

7%

2 year growth

30%